INSM – insmed incorporated (US:NASDAQ)

News

Insmed (INSM) had its "buy" rating reaffirmed by Roth Mkm. They now have a $212.00 price target on the stock.
Insmed (INSM) had its "buy" rating reaffirmed by Guggenheim.
Insmed (INSM) had its "outperform" rating reaffirmed by Royal Bank Of Canada.
Insmed (INSM) was upgraded by Raymond James Financial, Inc. to "moderate buy".
Insmed (INSM) is now covered by Raymond James Financial, Inc.. They set an "outperform" rating and a $200.00 price target on the stock.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com